申请人:Gosselin Gilles
公开号:US20070060505A1
公开(公告)日:2007-03-15
2′ and 3′-Prodrugs of 1′, 2′, 3′ or 4′-branched β-D or β-L nucleosides, or their pharmaceutically acceptable salts and derivatives are described, which are useful in the prevention and treatment of Flaviviridae infections and other related conditions. These modified nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses generally that replicate through an RNA dependent RNA reverse transcriptase. Compounds, compositions, methods and uses are provided for the treatment of Flaviviridae infection, including HCV infection, that include the administration of an effective amount of the prodrugs of the present invention, or their pharmaceutically acceptable salts or derivatives. These drugs may optionally be administered in combination or alteration with further anti-viral agents to prevent or treat Flaviviridae infections and other related conditions.
本文描述了1′、2′、3′或4′-支链β-D或β-L核苷的2′和3′-前药,或其药学上可接受的盐和衍生物,这些前药在预防和治疗黄病毒科感染和其他相关情况方面非常有用。这些修饰核苷对黄病毒和猪病毒,包括丙型肝炎病毒和通常通过RNA依赖RNA逆转录酶复制的病毒,提供了优越的效果。提供了化合物、组合物、方法和用途,用于治疗黄病毒科感染,包括HCV感染,其中包括给予本发明的前药或其药学上可接受的盐或衍生物的有效量的管理。这些药物可以选择性地与其他抗病毒药物结合或交替使用,以预防或治疗黄病毒科感染和其他相关情况。